Should Teva announce a meaningful setback here, we would expect MNTA shares to move above $20. [This is silly, IMO; why does Wedbush think Teva will be honest with investors about setbacks to the Lovenox ANDA?]
Unbelievably, Wedbush was more or less on to something here.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.